Rankings
▼
Calendar
RLAY Q1 2019 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$16M
Net Income
-$14M
EPS (Diluted)
$-4.59
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$14M
Stock-Based Comp.
$820,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$421M
Cash & Equivalents
-$422M
← FY 2019
All Quarters
Q2 2019 →